Considering that SMAD4 is the key component of the TGF-β pathway, it may be that mutant TP53 exerts a deleterious effect on the biological behavior of tumor cells harboring SMAD4 mutation; thus, the hazard for survival increases from single mutation to double mutation. The gene discussed is TGFB1; the disease is neoplasm.